View by Specialty

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

Cardiometabolic Disorders News

SPONSORED CONTENT
Save
SPONSORED CONTENT
June 05, 2024
5 min watch
Save

VIDEO: Inflammation ‘coming to the forefront’ of cardiovascular care

VIDEO: Inflammation ‘coming to the forefront’ of cardiovascular care

In this Healio video exclusive, Michael S. Garshick, MD, MS, discusses the role of inflammation in heart disease and how it has become a treatment target.

SPONSORED CONTENT
June 04, 2024
2 min read
Save

Evolocumab shows particular CV benefit in those with autoimmune disease, inflammation

Evolocumab shows particular CV benefit in those with autoimmune disease, inflammation

Patients with atherosclerosis and elevated LDL plus autoimmune or inflammatory disease may derive particular CV benefit from PCSK9 inhibition with evolocumab, a speaker reported.

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

SPONSORED CONTENT
June 04, 2024
4 min read
Save

Prevalence, economic burden of heart disease, stroke likely to rise greatly in US by 2050

Prevalence, economic burden of heart disease, stroke likely to rise greatly in US by 2050

Due to demographic changes and a rise in risk factors, the prevalence and economic burden of heart disease and stroke in the United States are expected to increase dramatically by 2050, according to the American Heart Association.

SPONSORED CONTENT
June 04, 2024
2 min read
Save

High insulin levels may drive worse breast cancer outcomes for Black women

High insulin levels may drive worse breast cancer outcomes for Black women

BOSTON — Tumor samples from Black women diagnosed with triple-negative breast cancer expressed higher levels of insulin signaling than samples from white women, suggesting hyperinsulinemia may play a role in disease outcomes, data show.

SPONSORED CONTENT
June 03, 2024
3 min read
Save

Plozasiran lowers APOC3, triglycerides, other lipids in high-risk populations

Plozasiran lowers APOC3, triglycerides, other lipids in high-risk populations

In patients with severe hypertriglyceridemia, plozasiran, a novel RNA interference agent, lowered apolipoprotein C-III and triglycerides and improved other lipid parameters, according to the final results of the phase 2b SHASTA-2 trial.

SPONSORED CONTENT
June 03, 2024
4 min watch
Save

VIDEO: Women’s heart disease risk factors should be assessed during menopause transition

VIDEO: Women’s heart disease risk factors should be assessed during menopause transition

In this Healio video exclusive, a speaker at the National Lipid Association Scientific Sessions discusses opportunities for heart disease prevention in women at the time of menopause transition.

SPONSORED CONTENT
June 02, 2024
2 min read
Save

Single excess weight measurement ‘does not seal one’s fate’ for heart-related events

Single excess weight measurement ‘does not seal one’s fate’ for heart-related events

BOSTON — Younger adults are at greater cardiovascular disease risk if they have obesity for 10 years, but a single excess weight measurement does not predict risk for heart-related events over time, according to data presented at ENDO 2024.

SPONSORED CONTENT
June 01, 2024
2 min read
Save

Sedentary children risk liver disease in young adulthood

Sedentary children risk liver disease in young adulthood

BOSTON — Accumulating sedentary time during childhood was associated with increased risk for liver disease in young adulthood, but boosting light physical activity may lessen the risk, according to data presented at ENDO 2024.

SPONSORED CONTENT
May 31, 2024
3 min read
Save

Priorities in obesity, CVD risk: optimizing body weight, atherogenic lipid levels

Priorities in obesity, CVD risk: optimizing body weight, atherogenic lipid levels

Patients with obesity are at increased risk for CVD, in part due to the promotion of an atherogenic lipid profile, according to a speaker.

SPONSORED CONTENT
May 31, 2024
3 min read
Save

Prenatal exposure to EDCs may increase metabolic syndrome risk for children

Prenatal exposure to EDCs may increase metabolic syndrome risk for children

Children exposed in utero to higher levels of some types of endocrine-disrupting chemicals have a higher risk for developing metabolic syndrome, according to findings published in JAMA Network Open.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails